Pharmaceutical composition comprising THA as active ingredient for treating breast cancer
AssigneeKorea United Pharm. Inc.
InventorsKeon Wook Kang, Kwang-Seok Oh, Youngchul Kim, Sung Baek Jeong
Life of this patent
Estimating the term…
Abstract
Provided is a composition comprising 2,4,6-trihydroxyacetophenone (THA) as an active ingredient, and a method for preventing, alleviating or treating breast cancer using the composition by inhibiting the activity of polo-like kinase 1 (PlK1).
Claims4
A method of treating breast cancer, the method comprising administering a pharmaceutical composition comprising 2,4,6-trihydroxyacetophenone (THA) as an active ingredient to an individual in need thereof, wherein the breast cancer is tamoxifen-resistant breast cancer.
A method of alleviating breast cancer, the method comprising administering a health functional food composition comprising 2,4,6-trihydroxyacetophenone(THA) as an active ingredient to an individual in need thereof, wherein the breast cancer is tamoxifen-resistant breast cancer.
Dependencies are inferred from the claim text.